CCL11 is a cytokine that induces MEK-1, ERK1/2, and STAT3 phosphoproteins as a mechanism for conferring anti-apoptotic and cisplatin-resistance potential in ovarian carcinoma [55]. The gene discussed is MAP2K1; the disease is ovarian carcinoma.